Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Brinsupri (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform...
FDA Grants Accelerated Approval to Hernexeos (zongertinib) for Previously Treated Patients with HER2-Mutant Advanced NSCLC
Ridgefield, Conn., U.S. and Ingelheim, Germany , August 8, 2025 -- Boehringer Ingelheim’s Hernexeos (zongertinib tablets) has been...
26.5 Percent of Adults With Diabetes Used GLP-1 RA Injectables in 2024
In 2024, 26.5 percent of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables, according to an August data...
Socioeconomic Deprivation Tied to Neurodegeneration in Combat Athletes
Athletes experiencing early-life socioeconomic disadvantage may have an increased risk for neurodegeneration from exposure to repetitive head injury (RHI),...
ADHD Drug Treatment Linked to Reduced Rate of Adverse Outcomes
Attention-deficit/hyperactivity disorder (ADHD) drug treatment is associated with reduced rates of adverse outcome events, including suicidality, substance...
2009 to 2023 Saw Increase in Use of Technology, Glycemic Control in Type 1 Diabetes
From 2009 to 2023, there was an increase in use of diabetes technology and in glycemic control among youths and adults with type 1 diabetes (T1D), according...
Fewer Americans Are Drinking Alcohol as Health Concerns Rise
THURSDAY, Aug. 14, 2025 — Fewer U.S. adults say they drink alcohol, and more now believe that even moderate drinking can harm their health, a new...
Wegmans Recalls Cheese Products Over Listeria Risk
THURSDAY, Aug. 14, 2025 — Wegmans is recalling several cheese products, including its medium camembert, because they may be contaminated with listeria,...
Sleeping Sickness Eliminated in Kenya, WHO Says
THURSDAY, Aug. 14, 2025 — The World Health Organization (WHO) has recognized Kenya as having eliminated human African trypanosomiasis (HAT), also...
Gut Docs Lose Their Edge Leaning On AI Assistance For Colonscopy
THURSDAY, Aug. 14, 2025 — Artificial intelligence (AI) is being touted as a means of improving doctors’ effectiveness, but the new tool might...
Conch Blowing Could Be Effective Treatment For Sleep Apnea
TUESDAY, Aug. 12, 2025 — Want to ease your sleep apnea and get a better night’s sleep? Blow through a conch shell, a new pilot clinical trial...
Novartis Ianalumab Phase III Trial Meets Primary Endpoint in ITP, Demonstrating Statistically Significant Improvement in Time to Treatment Failure
Basel, August 12, 2025 – Novartis today announced positive top-line results from VAYHIT2, a Phase III trial evaluating ianalumab plus eltrombopag...
Novartis Announces Both Ianalumab Phase III Clinical Trials Met Primary Endpoint in Patients with Sjögren’s Disease
Basel, August 11, 2025 – Novartis today announced positive top-line results from its Phase III trials evaluating ianalumab (VAY736) in adults...
Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
Arvinas, Inc. (Nasdaq: ARVN), today with its partner Pfizer Inc. (NYSE: PFE), announced that the U.S. Food and Drug Administration (FDA) has accepted the...
DermaRite Industries Issues Recall of DermaKleen, Dermasarra, Kleenfoam, and Perigiene Products Due to Burkholderia cepacia Contamination
DermaRite Industries, LLC is voluntarily recalling individual lots of products in the table below due to microbial contamination identified as Burkholderia...
Recently Added
Recently added consumer and prescribing information: Brinsupri, Zegfrovy, Lynozyfic, Arynta, Harliku, Ibtrozi, Miudella, Opdivo Qvantig, Alyftrek, Crenessity
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex CareNotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Brinsupri Brinsupri (brensocatib) is a dipeptidyl peptidase 1 inhibitor for the treatment of patients with bronchiectasis.
- Hernexeos Hernexeos (zongertinib) is a kinase inhibitor used for the treatment of non-squamous non-small cell lung cancer (NSCLC) with HER2 (ERBB2)...
- Modeyso Modeyso (dordaviprone) is a protease activator used for the treatment of diffuse midline glioma.